Quadrant Capital Group LLC Acquires 2,882 Shares of Becton, Dickinson and Company $BDX

30 Nov 2025, 08:58 by Renee Jackson · The Cerbat Gem

Quadrant Capital Group LLC boosted its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 86.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,233 shares of the medical instruments supplier’s stock after buying an additional 2,882 shares during the quarter. Quadrant Capital Group LLC’s holdings in Becton, Dickinson and Company were worth $1,074,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Saudi Central Bank acquired a new position in shares of Becton, Dickinson and Company during the 1st quarter worth approximately $26,000. Kelly Lawrence W & Associates Inc. CA acquired a new stake in Becton, Dickinson and Company during the 1st quarter valued at $31,000. Bell Investment Advisors Inc boosted its position in Becton, Dickinson and Company by 474.1% during the second quarter. Bell Investment Advisors Inc now owns 155 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 128 shares during the period. WPG Advisers LLC acquired a new position in shares of Becton, Dickinson and Company in the first quarter valued at $36,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its position in shares of Becton, Dickinson and Company by 378.9% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 182 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 144 shares during the period. 86.97% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Becton, Dickinson and Company news, Director Claire Fraser sold 917 shares of the firm’s stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $187.50, for a total value of $171,937.50. Following the transaction, the director directly owned 22,226 shares of the company’s stock, valued at $4,167,375. This trade represents a 3.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bertram L. Scott sold 217 shares of the company’s stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $176.58, for a total transaction of $38,317.86. Following the sale, the director directly owned 35,816 shares of the company’s stock, valued at approximately $6,324,389.28. This trade represents a 0.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 1,249 shares of company stock worth $231,358 in the last 90 days. 0.36% of the stock is owned by company insiders.

Analyst Ratings Changes

BDX has been the subject of several research analyst reports. Wall Street Zen downgraded shares of Becton, Dickinson and Company from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Royal Bank Of Canada lowered their price target on shares of Becton, Dickinson and Company from $211.00 to $202.00 and set a “sector perform” rating on the stock in a report on Friday, November 7th. Morgan Stanley boosted their price objective on Becton, Dickinson and Company from $196.00 to $197.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Piper Sandler decreased their target price on Becton, Dickinson and Company from $200.00 to $190.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Becton, Dickinson and Company in a report on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $203.27.

Get Our Latest Stock Analysis on BDX

Becton, Dickinson and Company Stock Up 0.1%

Shares of BDX opened at $194.00 on Friday. Becton, Dickinson and Company has a 12 month low of $162.29 and a 12 month high of $251.99. The firm’s 50 day moving average is $187.49 and its 200-day moving average is $183.14. The stock has a market capitalization of $55.37 billion, a PE ratio of 34.89, a P/E/G ratio of 1.42 and a beta of 0.25. The company has a current ratio of 1.10, a quick ratio of 0.62 and a debt-to-equity ratio of 0.69.

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) last issued its quarterly earnings results on Thursday, April 14th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter. The business had revenue of $5.32 billion during the quarter. Becton, Dickinson and Company had a return on equity of 16.23% and a net margin of 7.51%. Equities research analysts forecast that Becton, Dickinson and Company will post 14.43 EPS for the current year.

Becton, Dickinson and Company Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 31st. Investors of record on Monday, December 8th will be given a $1.05 dividend. The ex-dividend date is Monday, December 8th. This is an increase from Becton, Dickinson and Company’s previous quarterly dividend of $1.04. This represents a $4.20 dividend on an annualized basis and a dividend yield of 2.2%. Becton, Dickinson and Company’s dividend payout ratio (DPR) is 72.04%.

Becton, Dickinson and Company Profile

(Free Report)